In a nationwide survey, females were less likely than males to report having discussed lung cancer screening with their healthcare provider regardless of smoking status, though these results did not reach statistical significance, and 32% less likely to have heard of LDCT (OR, 0.68; 95% CI: 0.47–0.99).
← all excerpts
Lung cancer in females-sex-based differences from males in epidemiology, biology, and outcomes: a narrative review.
1
—
—